These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20557356)

  • 21. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.
    Savage WJ; Kickler TS; Takemoto CM
    Pediatr Blood Cancer; 2007 Dec; 49(7):1025-9. PubMed ID: 16526049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin].
    Miesbach W; Voigt J; Peetz D; Scharrer I
    Med Klin (Munich); 2003 Jun; 98(6):339-43. PubMed ID: 12811419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
    Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
    Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation inhibitors.
    Corrigan JJ
    Am J Pediatr Hematol Oncol; 1980; 2(3):281-8. PubMed ID: 6776839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep vein thrombosis associated with factor V inhibitor followed by immune thrombocytopenia.
    Higuchi T; Okamoto T; Kou T; Takeuchi T; Koyamada R; Okada S
    Ann Hematol; 2012 Nov; 91(11):1831-2. PubMed ID: 22588327
    [No Abstract]   [Full Text] [Related]  

  • 26. Acquired factor V inhibitor and single exposure to autologous growth factor.
    Shah AK; Moreno-Aspitia A
    Thromb Res; 2005; 116(1):87-9. PubMed ID: 15850612
    [No Abstract]   [Full Text] [Related]  

  • 27. Venous thromboembolism in a patient with persistent inhibitor to coagulation factor V - a case report.
    Rief P; Hackl G; Hafner F; Raggam RB; Wölfler A; Brodmann M; Gary T
    Clin Chem Lab Med; 2016 Sep; 54(9):e269-71. PubMed ID: 26910745
    [No Abstract]   [Full Text] [Related]  

  • 28. Acquired factor V inhibitor-related severe bleeding due to unformed prothrombinase complex.
    Mitsuhashi T; Takamiya O
    Thromb Res; 2018 Nov; 171():81-83. PubMed ID: 30267973
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case positive for the inhibitor for coagulation factor V].
    Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
    Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anesthetic management of a patient with acquired factor V inhibitor].
    Nakamura T; Otsuji M; Kurita A; Yamada K; Tsubokawa T; Yamamoto K
    Masui; 2010 Nov; 59(11):1423-7. PubMed ID: 21077315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acquired inhibitor of factor V: an uncommon cause of prolonged coagulation tests].
    Hernández JA; Alonso A; Bermejo A; Velayos C
    Med Clin (Barc); 2006 Mar; 126(9):359. PubMed ID: 16650377
    [No Abstract]   [Full Text] [Related]  

  • 32. [A long-lasting idiopathic factor V inhibitor].
    Okoshi Y; Akiyama H; Inoue T; Koyama T; Kono N; Matsumura T; Mizuchi D; Mori S; Ohashi K; Sakamaki H
    Rinsho Ketsueki; 2003 Jan; 44(1):14-8. PubMed ID: 12649832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
    Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H
    Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor V inhibitor associated with immune complex formation.
    Lazarchick J; Wolff CM; Pepkowitz SH; Kizer J; Romein LA
    Arch Pathol Lab Med; 1986 May; 110(5):448-51. PubMed ID: 3754431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of cephradine-induced acquired factor V inhibitors: a case report.
    Wu MT; Pei SN
    Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.
    Hoffmann C; Amiral J; Rezig S; Kerspern H; Jantzem H; Robin S; Collins A; Mornet C; Mingant F; Pan Petesch B; Ianotto JC; Lippert E; Galinat H
    Eur J Haematol; 2019 Aug; 103(2):137-139. PubMed ID: 31102471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant.
    Green D; Hougie C; Kazmier FJ; Lechner K; Mannucci PM; Rizza CR; Sultan Y
    Thromb Haemost; 1983 Apr; 49(2):144-6. PubMed ID: 6408752
    [No Abstract]   [Full Text] [Related]  

  • 38. Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment.
    Sakatoku K; Takakuwa T; Miura A; Araki T; Fujitani Y; Yamamura R
    Acta Haematol; 2020; 143(5):478-480. PubMed ID: 31522179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Simultaneous presence of inhibitors of factors V and VII or antiprothrombinase anticoagulants].
    Ordi Ros J; Vila Baucells M; Vilardell Tarres M
    Med Clin (Barc); 1983 Sep; 81(8):368-9. PubMed ID: 6645694
    [No Abstract]   [Full Text] [Related]  

  • 40. Hematuria in a Former Smoker.
    Olson NJ; Ornstein DL
    Clin Chem; 2017 Nov; 63(11):1774. PubMed ID: 29089324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.